|Videos|December 22, 2022
Stages and Progression of T1D
Kimberly Simmons, MD, reviews stages 1, 2, and 3 of pediatric T1D progression.
Advertisement
Episodes in this series
Advertisement
Related to this article
Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.
ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.
FDA authorized Abbott's Libre Duo 10 Day, the first wearable that continuously tracks glucose and ketones, for patients 2 and older with diabetes.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves baricitinib for adolescents with severe alopecia areata
2
FDA approves obinutuzumab to reduce relapse risk in childhood-onset idiopathic nephrotic syndrome
3
FAQ: How should pediatricians hand off teens with diabetes?
4
GLP-1 receptor agonists tied to nutritional deficiencies in children, study finds
5